BindingDB logo
myBDB logout

BDBM85812 Des-AA11-18[Cys7,21,D-Lys9 (Ac), D-His26, Pro34]-NPY

SMILES:

InChI Key: InChIKey=QLQLIXCAJCKQSN-LMCQCTQASA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 85812   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM85812
PNG
(Des-AA11-18[Cys7,21,D-Lys9 (Ac), D-His26, Pro34]-N...)
Show InChI InChI=1S/C163H252N48O45S2/c1-13-83(7)127(153(250)200-112(72-123(166)220)142(239)194-108(66-82(5)6)144(241)206-128(84(8)14-2)154(251)207-129(87(11)214)155(252)191-105(32-22-60-181-163(174)175)158(255)209-62-24-34-120(209)149(246)189-102(31-21-59-180-162(172)173)134(231)192-106(130(167)227)68-90-39-47-95(217)48-40-90)205-145(242)110(70-92-43-51-97(219)52-44-92)196-141(238)111(71-93-75-176-80-182-93)197-136(233)101(30-20-58-179-161(170)171)186-139(236)107(65-81(3)4)193-132(229)86(10)184-146(243)115(76-212)201-148(245)117(78-257)203-140(237)109(69-91-41-49-96(218)50-42-91)195-135(232)100(29-19-57-178-160(168)169)185-131(228)85(9)183-138(235)113(73-125(223)224)198-137(234)103(53-54-124(221)222)187-133(230)99(27-16-18-56-177-88(12)215)188-150(247)121-35-26-64-211(121)159(256)118(79-258)204-143(240)114(74-126(225)226)199-151(248)122-36-25-63-210(122)157(254)104(28-15-17-55-164)190-147(244)116(77-213)202-152(249)119-33-23-61-208(119)156(253)98(165)67-89-37-45-94(216)46-38-89/h37-52,75,80-87,98-122,127-129,212-214,216-219,257-258H,13-36,53-74,76-79,164-165H2,1-12H3,(H2,166,220)(H2,167,227)(H,176,182)(H,177,215)(H,183,235)(H,184,243)(H,185,228)(H,186,236)(H,187,230)(H,188,247)(H,189,246)(H,190,244)(H,191,252)(H,192,231)(H,193,229)(H,194,239)(H,195,232)(H,196,238)(H,197,233)(H,198,234)(H,199,248)(H,200,250)(H,201,245)(H,202,249)(H,203,237)(H,204,240)(H,205,242)(H,206,241)(H,207,251)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,178)(H4,170,171,179)(H4,172,173,180)(H4,174,175,181)/t83-,84-,85-,86-,87+,98-,99?,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111+,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,127-,128-,129-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

PubMed
1.20n/an/an/an/an/an/an/an/a



Schering-Plough Research Institute

Curated by PDSP Ki Database




Mol Pharmacol 60: 534-40 (2001)


BindingDB Entry DOI: 10.7270/Q2BC3X35
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 4


(Homo sapiens (Human))
BDBM85812
PNG
(Des-AA11-18[Cys7,21,D-Lys9 (Ac), D-His26, Pro34]-N...)
Show InChI InChI=1S/C163H252N48O45S2/c1-13-83(7)127(153(250)200-112(72-123(166)220)142(239)194-108(66-82(5)6)144(241)206-128(84(8)14-2)154(251)207-129(87(11)214)155(252)191-105(32-22-60-181-163(174)175)158(255)209-62-24-34-120(209)149(246)189-102(31-21-59-180-162(172)173)134(231)192-106(130(167)227)68-90-39-47-95(217)48-40-90)205-145(242)110(70-92-43-51-97(219)52-44-92)196-141(238)111(71-93-75-176-80-182-93)197-136(233)101(30-20-58-179-161(170)171)186-139(236)107(65-81(3)4)193-132(229)86(10)184-146(243)115(76-212)201-148(245)117(78-257)203-140(237)109(69-91-41-49-96(218)50-42-91)195-135(232)100(29-19-57-178-160(168)169)185-131(228)85(9)183-138(235)113(73-125(223)224)198-137(234)103(53-54-124(221)222)187-133(230)99(27-16-18-56-177-88(12)215)188-150(247)121-35-26-64-211(121)159(256)118(79-258)204-143(240)114(74-126(225)226)199-151(248)122-36-25-63-210(122)157(254)104(28-15-17-55-164)190-147(244)116(77-213)202-152(249)119-33-23-61-208(119)156(253)98(165)67-89-37-45-94(216)46-38-89/h37-52,75,80-87,98-122,127-129,212-214,216-219,257-258H,13-36,53-74,76-79,164-165H2,1-12H3,(H2,166,220)(H2,167,227)(H,176,182)(H,177,215)(H,183,235)(H,184,243)(H,185,228)(H,186,236)(H,187,230)(H,188,247)(H,189,246)(H,190,244)(H,191,252)(H,192,231)(H,193,229)(H,194,239)(H,195,232)(H,196,238)(H,197,233)(H,198,234)(H,199,248)(H,200,250)(H,201,245)(H,202,249)(H,203,237)(H,204,240)(H,205,242)(H,206,241)(H,207,251)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,178)(H4,170,171,179)(H4,172,173,180)(H4,174,175,181)/t83-,84-,85-,86-,87+,98-,99?,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111+,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,127-,128-,129-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

PubMed
31.4n/an/an/an/an/an/an/an/a



Schering-Plough Research Institute

Curated by PDSP Ki Database




Mol Pharmacol 60: 534-40 (2001)


BindingDB Entry DOI: 10.7270/Q2BC3X35
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM85812
PNG
(Des-AA11-18[Cys7,21,D-Lys9 (Ac), D-His26, Pro34]-N...)
Show InChI InChI=1S/C163H252N48O45S2/c1-13-83(7)127(153(250)200-112(72-123(166)220)142(239)194-108(66-82(5)6)144(241)206-128(84(8)14-2)154(251)207-129(87(11)214)155(252)191-105(32-22-60-181-163(174)175)158(255)209-62-24-34-120(209)149(246)189-102(31-21-59-180-162(172)173)134(231)192-106(130(167)227)68-90-39-47-95(217)48-40-90)205-145(242)110(70-92-43-51-97(219)52-44-92)196-141(238)111(71-93-75-176-80-182-93)197-136(233)101(30-20-58-179-161(170)171)186-139(236)107(65-81(3)4)193-132(229)86(10)184-146(243)115(76-212)201-148(245)117(78-257)203-140(237)109(69-91-41-49-96(218)50-42-91)195-135(232)100(29-19-57-178-160(168)169)185-131(228)85(9)183-138(235)113(73-125(223)224)198-137(234)103(53-54-124(221)222)187-133(230)99(27-16-18-56-177-88(12)215)188-150(247)121-35-26-64-211(121)159(256)118(79-258)204-143(240)114(74-126(225)226)199-151(248)122-36-25-63-210(122)157(254)104(28-15-17-55-164)190-147(244)116(77-213)202-152(249)119-33-23-61-208(119)156(253)98(165)67-89-37-45-94(216)46-38-89/h37-52,75,80-87,98-122,127-129,212-214,216-219,257-258H,13-36,53-74,76-79,164-165H2,1-12H3,(H2,166,220)(H2,167,227)(H,176,182)(H,177,215)(H,183,235)(H,184,243)(H,185,228)(H,186,236)(H,187,230)(H,188,247)(H,189,246)(H,190,244)(H,191,252)(H,192,231)(H,193,229)(H,194,239)(H,195,232)(H,196,238)(H,197,233)(H,198,234)(H,199,248)(H,200,250)(H,201,245)(H,202,249)(H,203,237)(H,204,240)(H,205,242)(H,206,241)(H,207,251)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,178)(H4,170,171,179)(H4,172,173,180)(H4,174,175,181)/t83-,84-,85-,86-,87+,98-,99?,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111+,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,127-,128-,129-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

PubMed
801n/an/an/an/an/an/an/an/a



Schering-Plough Research Institute

Curated by PDSP Ki Database




Mol Pharmacol 60: 534-40 (2001)


BindingDB Entry DOI: 10.7270/Q2BC3X35
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 5


(Homo sapiens (Human))
BDBM85812
PNG
(Des-AA11-18[Cys7,21,D-Lys9 (Ac), D-His26, Pro34]-N...)
Show InChI InChI=1S/C163H252N48O45S2/c1-13-83(7)127(153(250)200-112(72-123(166)220)142(239)194-108(66-82(5)6)144(241)206-128(84(8)14-2)154(251)207-129(87(11)214)155(252)191-105(32-22-60-181-163(174)175)158(255)209-62-24-34-120(209)149(246)189-102(31-21-59-180-162(172)173)134(231)192-106(130(167)227)68-90-39-47-95(217)48-40-90)205-145(242)110(70-92-43-51-97(219)52-44-92)196-141(238)111(71-93-75-176-80-182-93)197-136(233)101(30-20-58-179-161(170)171)186-139(236)107(65-81(3)4)193-132(229)86(10)184-146(243)115(76-212)201-148(245)117(78-257)203-140(237)109(69-91-41-49-96(218)50-42-91)195-135(232)100(29-19-57-178-160(168)169)185-131(228)85(9)183-138(235)113(73-125(223)224)198-137(234)103(53-54-124(221)222)187-133(230)99(27-16-18-56-177-88(12)215)188-150(247)121-35-26-64-211(121)159(256)118(79-258)204-143(240)114(74-126(225)226)199-151(248)122-36-25-63-210(122)157(254)104(28-15-17-55-164)190-147(244)116(77-213)202-152(249)119-33-23-61-208(119)156(253)98(165)67-89-37-45-94(216)46-38-89/h37-52,75,80-87,98-122,127-129,212-214,216-219,257-258H,13-36,53-74,76-79,164-165H2,1-12H3,(H2,166,220)(H2,167,227)(H,176,182)(H,177,215)(H,183,235)(H,184,243)(H,185,228)(H,186,236)(H,187,230)(H,188,247)(H,189,246)(H,190,244)(H,191,252)(H,192,231)(H,193,229)(H,194,239)(H,195,232)(H,196,238)(H,197,233)(H,198,234)(H,199,248)(H,200,250)(H,201,245)(H,202,249)(H,203,237)(H,204,240)(H,205,242)(H,206,241)(H,207,251)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,178)(H4,170,171,179)(H4,172,173,180)(H4,174,175,181)/t83-,84-,85-,86-,87+,98-,99?,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111+,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,127-,128-,129-/m0/s1
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

PubMed
2.36E+3n/an/an/an/an/an/an/an/a



Schering-Plough Research Institute

Curated by PDSP Ki Database




Mol Pharmacol 60: 534-40 (2001)


BindingDB Entry DOI: 10.7270/Q2BC3X35
More data for this
Ligand-Target Pair